W, W., H, L., J, G., & Y, L. (2025). Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer. Clinical and experimental medicine, 25(1), 253. https://doi.org/10.1007/s10238-025-01801-0
Chicago Style (17th ed.) CitationW, Wang, Li H, Gong J, and Liu Y. "Identification of a Fibroblast-derived Gene Signature Reveals Prognostic and Therapeutic Insights in Pancreatic Cancer." Clinical and Experimental Medicine 25, no. 1 (2025): 253. https://doi.org/10.1007/s10238-025-01801-0.
MLA (9th ed.) CitationW, Wang, et al. "Identification of a Fibroblast-derived Gene Signature Reveals Prognostic and Therapeutic Insights in Pancreatic Cancer." Clinical and Experimental Medicine, vol. 25, no. 1, 2025, p. 253, https://doi.org/10.1007/s10238-025-01801-0.